UM

Browse/Search Results:  1-10 of 71 Help

Selected(0)Clear Items/Page:    Sort:
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges Review article
2024
Authors:  Li, Chang Yun;  Wang, Wanhe;  Leung, Chung Hang;  Yang, Guan Jun;  Chen, Jiong
Favorite | TC[WOS]:2 TC[Scopus]:4  IF:27.7/31.3 | Submit date:2024/06/05
Breast Cancer  Histone Demethylation  Kdm5  Kdm5 Inhibitors  Therapeutic Target  
Synergistic inhibition effect of Chlorella sp. and benzotriazole on the corrosion of Q235 carbon steel in alkaline artificial seawater Journal article
Chen, Shan, Zhang, Shen, Yuan, Mingzhe, Zhang, Ping. Synergistic inhibition effect of Chlorella sp. and benzotriazole on the corrosion of Q235 carbon steel in alkaline artificial seawater[J]. Scientific Reports, 2024, 14(1), 24547.
Authors:  Chen, Shan;  Zhang, Shen;  Yuan, Mingzhe;  Zhang, Ping
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:3.8/4.3 | Submit date:2024/11/05
Corrosion Inhibition  Synergistic Effect  Biological And Chemical Inhibitors  Alkaline Artificial Seawater  Q235 Carbon Steel  
Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy Journal article
Dong, Lei, Zhu, Yini, Zhang, Haoge, Gao, Lin, Zhang, Zhiqi, Xu, Xiaoxuan, Ying, Leqian, Zhang, Lu, Li, Yue, Yun, Zhengcheng, Zhu, Danqi, Han, Chang, Xu, Tingting, Yang, Hui, Ju, Shenghong, Chen, Xiaoyuan, Zhang, Haijun, Xie, Jinbing. Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy[J]. Advanced Materials, 2024.
Authors:  Dong, Lei;  Zhu, Yini;  Zhang, Haoge;  Gao, Lin;  Zhang, Zhiqi; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:27.4/30.2 | Submit date:2024/10/10
Cxcl10  Glioblastoma  Il-2  Immune Checkpoint Inhibitors  Immunosuppressive Microenvironment  Low-frequency Focused Ultrasound  T-cell Exhaustion  
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis Journal article
Ying Liu, Ella Man-Wai Un, Ying Bai, Man Keong Chan, Luo Xin Zeng, Sut Leng Lei, Junjun Li, UNG OI LAM CAROLINA. Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis[J]. Journal of Pharmacy & Pharmaceutical Sciences, 2024, 27, 13206.
Authors:  Ying Liu;  Ella Man-Wai Un;  Ying Bai;  Man Keong Chan;  Luo Xin Zeng; et al.
Adobe PDF | Favorite | TC[WOS]:1 TC[Scopus]:1  IF:2.9/2.6 | Submit date:2024/08/27
Fetal Growth Restriction  Intrauterine Growth Restriction  Phosphodiesterase-5 Inhibitors  Sildenafil  Tadalafil  
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review Review article
2024
Authors:  Hassan, Ahmed Mostafa Ibrahim Abdelrahman;  Zhao, Yuxin;  Chen, Xiuping;  He, Chengwei
Adobe PDF | Favorite | TC[WOS]:6 TC[Scopus]:5  IF:4.9/5.6 | Submit date:2024/08/05
Autophagy Inhibitors  Cancer Therapy  Clinical Trials  
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review Journal article
Hassan, Ahmed Mostafa Ibrahim Abdelrahman, Zhao, Yuxin, Chen, Xiuping, He, Chengwei. Blockage of Autophagy for Cancer Therapy: A Comprehensive Review[J]. International Journal of Molecular Sciences, 2024, 25(13).
Authors:  Hassan, Ahmed Mostafa Ibrahim Abdelrahman;  Zhao, Yuxin;  Chen, Xiuping;  He, Chengwei
Favorite | TC[WOS]:6 TC[Scopus]:5  IF:4.9/5.6 | Submit date:2024/10/10
autophagy inhibitors  cancer therapy  clinical trials  
来源于桑属植物的DA加合物在制备β-G抑制剂中的应用 Patent
专利类型: 发明专利 Invention, 专利号: CN114796194B, 申请日期: 2022-05-27,
Authors:  燕茹;  王盼盼;  陈智强
Favorite |  | Submit date:2022/08/15
Β-glucuronidases Inhibitors  Gut Microbiota  Diels–alder Adducts  Morus Plants  Applications  
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's disease Other
2024-04-01
Authors:  He, Junqiu;  Tam, Kin Yip
Favorite | TC[WOS]:2 TC[Scopus]:3 | Submit date:2024/05/02
Alzheimer's Disease  Cholinesterase  Drug Design Strategy  Dual-target Inhibitors  Gsk-3β  
Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease Journal article
He Junqiu, TAM KIN YIP. Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease[J]. Drug Discovery Today, 2024, 29(4), 1-8.
Authors:  He Junqiu;  TAM KIN YIP
Adobe PDF | Favorite | TC[WOS]:2 TC[Scopus]:3  IF:6.5/7.3 | Submit date:2024/08/29
Gsk-3b  Cholinesterase  Dual-target Inhibitors  Alzheimer’s Disease  Drug Design Strategy  
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:6.1/6.7 | Submit date:2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors